Biomea Fusion Inc (BMEA) Stock Analysis
Verdict: HOLD
Severe 9.5-month cash burn forces dilution risk, capping upside from BMF-219 clinical progress despite insider purchases and EPS beats.
Investment score: 45/100
Analysis as of
Is Biomea Fusion Inc stock worth reviewing? AI model thesis
The model score of 45/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 42/100 (weight 15%)
- Earnings Quality: 68/100 (weight 15%)
- Insider Sentiment: 65/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
Biomea Fusion Inc opportunities and risks
What speaks for BMEA
- BMF-219 Covalent Menin Platform Option Value
What speaks against BMEA
- Imminent Dilution Overhang from 9.5-Month Cash Runway
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BMEA | n/a | 0.0x | n/a | 0.0% | 0.0% | -47.5% |
| COYA | n/a | 14.2x | 1951.3x | 99.9% | -270.2% | -11976.7% |
| XGN | n/a | 2.7x | n/a | 58.6% | -26.6% | -4.0% |
| CADL | n/a | 0.0x | n/a | 0.0% | 0.0% | -6.0% |
| PTHS | n/a | 2.0x | n/a | 54.7% | -165.2% | -48.0% |
| ATRA | n/a | 14.1x | n/a | 91.4% | -269.4% | -25.1% |
| Peer median | n/a | 2.7x | n/a | 58.6% | -165.2% | -25.1% |
Frequently asked questions about Biomea Fusion Inc (BMEA)
Is BMEA stock a good investment?
The cached TradeMates AI model rates Biomea Fusion Inc as HOLD with an investment score of 45/100. The model score of 45/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is BMEA stock a buy?
The TradeMates model verdict for BMEA is HOLD with an investment score of 45/100. Treat this as a model signal to review, not a personal buy recommendation.